The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

por Kohli, Michele A., Maschio, Michael, Cartier, Shannon, Mould-Quevedo, Joaquin, Fricke, Frank-Ulrich
Publicado 2022

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

por Kaló, Zoltán, Petykó, Zsuzsanna Ida, Fricke, Frank-Ulrich, Maniadakis, Nikos, Tesař, Tomáš, Podrazilová, Kateřina, Espin, Jaime, Inotai, András
Publicado 2021

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

por Petykó, Zsuzsanna Ida, Kaló, Zoltán, Espin, Jaime, Podrazilová, Kateřina, Tesař, Tomáš, Maniadakis, Nikos, Fricke, Frank-Ulrich, Inotai, András
Publicado 2021

Health economic evaluation of gene replacement therapies: methodological issues and recommendations

por Aballéa, Samuel, Thokagevistk, Katia, Velikanova, Rimma, Simoens, Steven, Annemans, Lieven, Antonanzas, Fernando, Auquier, Pascal, François, Clément, Fricke, Frank-Ulrich, Malone, Daniel, Millier, Aurélie, Persson, Ulf, Petrou, Stavros, Dabbous, Omar, Postma, Maarten, Toumi, Mondher
Publicado 2020